Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
2007 ◽
Vol 282
(12)
◽
pp. 8741-8748
◽
1995 ◽
Vol 29
(6)
◽
pp. 841-847
◽
2015 ◽
2008 ◽
Vol 14
(1)
◽
pp. 37-41
◽